Company: FTII
Filing Date: 2025-02-14
Form Type: S-4
Source: 0001493152-25-006997
Chunk: 609

Company: FutureTech II Acquisition Corp.
Filing Date: 2025-02-14
Form: S-4
Chunk 609
---
, with respect to the conduct of business prior to the closing of the Merger Transactions.

The Merger Agreement may be terminated under certain circumstances including:

| ● | By                                              
 mutual written consent of Longevity and Denali. |

| ● | By                                                                                              
 either Longevity or Denali if any of the conditions to the closing have not been satisfied      
 or waived by the nine-month anniversary of the date of the Merger Agreement, subject to certain 
 extension options available to Denali.                                                          |

| ● | By                                                                                            
 either Longevity or Denali if any governmental authority of competent jurisdiction has issued 
 an order that has become final and non-appealable and has the effect of making consummation   
 of the Merger Transactions illegal or otherwise preventing or prohibiting consummation of     
 the Merger Transactions.                                                                      |

| ● | By                                                                                            
 the non-breaching party if there is a material breach by one or more of the other parties     
 of any of their respective representations, warranties, covenants or agreements contained     
 in the Merger Agreement, or if any such representation or warranty shall have become untrue   
 or inaccurate and the breach or inaccuracy is incapable of being cured or is not cured within 
 the timeframes specified in the Merger Agreement.                                             |

| ● | By                                                                                               
 Denali if there has been a Material Adverse Effect (as defined in the Merger Agreement) on       
 Longevity and the Target Companies, taken as a whole, following the date of the Merger Agreement 
 which is uncured within the time frame specified in the Merger Agreement.                        |

| ● | By                                                                                        
 either Longevity or Denali if any of the required proposals fail to receive the requisite 
 vote for approval by Denali’s shareholders.                                               |

First Amendment to the C&E Agreement

On January 25, 2023, the Company and each of its unitholders entered into an amendment to the C&E Agreement with Longevity pursuant to which certain provisions of the C&E Agreement were amended to, among other things: modify the aggregate valuation assigned to Longevity reflecting the Acquisition Transactions to match that agreed to in the Merger Agreement, modify the allocation of the transaction consideration among the Target Companies to match that agreed to in the Merger Agreement, modify the minimum cash balance at closing of the Business Combination to match that agreed to in the Merger Agreement, and, conform certain representations, warranties, covenants, closing conditions, termination provisions, and other provisions of the C&E Agreement to the Mer